scholarly journals (New European standards of care of patients with terminal heart failure and their application in the Czech health system)

Cor et Vasa ◽  
2020 ◽  
Vol 62 (1) ◽  
pp. 70-71
Author(s):  
Ladislav Kabelka
2019 ◽  
Vol 9 (6) ◽  
pp. 37-44
Author(s):  
Andrea Marie Medina Méndez ◽  
Henry Ulate Arguedas ◽  
Andrea Marie Medina Méndez

Resumen en español Introducción: Los beneficios que los CP aportan a los pacientes con enfermedad oncológica, están claramente establecido desde hace años, no así los beneficios que podrían recibir los pacientes con IC.  Objetivos: Evidenciar los beneficios de la inclusión de los CP a los servicios de Cardiología y determinar el manejo de los pacientes con IC avanzada/terminal.  Métodos: Se realizó una búsqueda de estudios relacionados con el tema en diferentes bases de datos: Cochrane Medline, Medscape, PubMed Scielo y Tripdatabase en el mes de Setiembre del 2018 utilizando las palabras claves.  Resultados y conclusiones: La inclusión temprana de los pacientes con IC avanzada o terminal en los programas de CP trae importantes beneficios para el pacientes su familia/cuidador y al sistema de salud.     Abstract Introduction: The benefits that palliative care provides to patients with oncological disease are clearly established for years, but not the benefits that patients with heart failure could receive. Objectives: To demonstrate the benefits of the inclusion of palliative care to Cardiology services and to determine the management of patients with advanced/terminal heart failure. Methods: A search of related studies was carried out in different databases: Cochrane Medline, Medscape, PubMed Scielo and Tripdatabase in the month of September 2018 using the key words. Results and conclusions: The early inclusion of patients with advanced or terminal heart failure in palliative care programs brings important benefits for patients, their family / caregiver and the health system.


2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
S Perez-Ortega ◽  
J Prats ◽  
E Querol

Abstract Background The introduction of veno-arterial extracorporeal life support (v-a ECLS) widens the spectrum of patients that can be included in the heart transplant program, some examples are extended myocardial infarction, fulminant myocarditis or advanced cardiac insufficiency. In addition to this, the implementation of extracorporeal cardiopulmonary resuscitation (ECPR) extends even more the range of patients that can be benefitted of this therapy as a bridge to transplant. Purpose Our objective is to describe the incidence of v-a ECLS in those patients submitted to a heart transplant and to establish whether or not this technique increases the risk of mortality in this population. Methods Retrospective and descriptive statistical analysis of 82 consecutive patients submitted to heart transplant between 2015 and 2019 in a High Technology University Hospital. Demographic and clinical data, extracorporeal life support, extracorporeal cardiopulmonary resuscitation and assistance device type, together with survival at 30 days and one year were collected. Results 82 patients were transplanted during the study period distributed as follows: 47 (51.69%) were elective and 35 (48.1%) emergent being 25 (30.12%) of grade 1A and 10 (12.19%) of grade 1B. 52% had prior intra-aortic balloon contrapulsation. Patients transplanted under ECLS were 80% men and average age of 53 (SD 15) years old. The most prevalent diagnosis was acute myocardial infarction Killip IV (32%), followed by terminal heart failure (28%). 32% of the patients were under peripheral ECMO, 36% under left ventricular assistance, 20% under biventricular assist device, and 12% required ECPR. 72% of devices were implanted in the operating room and 16% in the ICU. The one-year survival of the sample was 88%. 2 patients died after transplantation (8%) during the first month, and 1 patient died within the first year. All three patients had terminal heart failure and the VAD implant was inserted electively Conclusions ECLS prior to cardiac transplantation allow selected patients to arrive alive to the transplant. The choice among devices is related to the diagnosis and expected duration of the therapy but we have not found in our series effects on subsequent mortality. Survival at one year in the subjects analysed is greater than the national registry of the last 10 years, although the tendency is to improve every year. This new scenario implies an increment of the complexity in the management of these patients and requires an special effort in terms of staff ratio and training. In our centre, the implementation of ECLS resulted in an increment of our staff and formative sessions. Funding Acknowledgement Type of funding source: None


2018 ◽  
Vol 122 (2) ◽  
pp. 275-278 ◽  
Author(s):  
Marat Fudim ◽  
Lukasz P. Cerbin ◽  
Srikant Devaraj ◽  
Tarek Ajam ◽  
Sunil V. Rao ◽  
...  

2021 ◽  
Vol 12 (4) ◽  
pp. 21
Author(s):  
Virna Ribeiro Feitosa Cestari ◽  
Lorena C. De Souza ◽  
Raquel S. Florêncio ◽  
Maria G.V. Sobral ◽  
Vera L.M.P. Pessoa ◽  
...  

Objective: To understand the expectations of the professionals about the construction and use of an educational and follow-up application to care.Methods: Phenomenological and qualitative study. Convenience and purposive sampling were carried out and in-depth individual interviews with 35 professionals from the multidisciplinary team, between September and October 2020 in Brazil. All interviews were audio-recorded and data analyzed using the hermeneutic circle. The COREQ checklist was employed to report on the current study.Results: Two main units of meaning emerged: (a) The care of the person who lives with heart failure; and (b) The care of the person with heart failure intermediated by an application. Care for the person with the disease brings together elements related to the identification of demands and understanding of their surroundings, with guidance and use of technologies.Conclusions: The professionals were favorable to the development of an application and considered it beneficial. The use of it, would allow the approximation between patients and their family and the multidisciplinary team; respect the patient’s needs and overcome the precariousness of the health system.


Author(s):  
Peter Baldwin

The U.S. Economy does Differ from Europe’s: a less regulated labor market, but also an economy that is more hemmed in than might be expected. By European standards, America has hardish-working people, a state that collects fewer tax dollars, and workers who are paid well even if their holidays are short. In social policy, the contrasts are more moderate. Europeans commonly believe that the United States simply has no social policy—no social security, no unemployment benefits, no state pensions, and no assistance for the poor. As Jean-François Revel, the political philosopher and académicien, summed up French criticism, the United States shows “not the slightest bit of social solidarity.” Will Hutton similarly assures us that “The structures that support ordinary peoples’ lives—free health care, quality education, guarantees of reasonable living standards in old age, sickness or unemployment, housing for the disadvantaged— that Europeans take for granted are conspicuous by their absence.” And, in fact, the United States is the only developed nation, unless one counts South Africa, without some form of national health insurance, which is to say a system of requiring all its citizens to be insured in one way or another. This lack of universal health insurance is the one fact that every would-be comparativist working across the Atlantic knows, and the first one to be hoisted as the battle is engaged. One of the first attempts to quantify and rank health care performance, by the World Health Organization in 2000, gave the American system its due. Overall, it came in below any of our comparison countries, three notches under Denmark. In various specific aspects of health policy, it did better. For disability adjusted life expectancy, it came in above Ireland, Denmark, and Portugal; on the responsiveness of the health system, it ranked first; on a composite measure of various indicators summed up as “overall health system attainment,” it ranked above seven Western European countries. Even on the measure of “fairness of financial contribution to health systems,” where we might have expected an abysmal rating, the United States squeaked in above Portugal. That is, of course, damning with faint praise, especially given that in this particular aspect of the ranking—a well-meaning but other-worldly attempt by international bureaucrats to rake the entire globe over the teeth of one comb—Colombia came in first, outpacing its close rivals, Luxembourg and Belgium, while Libya beat out Sweden.


Sign in / Sign up

Export Citation Format

Share Document